...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Was checking out SEDAR...
6
Mar 28, 2022 02:40PM
4
Mar 28, 2022 03:48PM

accchhhh,,,,these companies which DMcC supposedly directs has actullay simply been a personal bank for the senior team,,,,as they seem to have no control over what direction the companies go in. It is very clear to me that DMcC has no hands on with either company and has no infulence in either. The blabber that has been given to shareholders and the lack of progress these past 2 1/2 years are proof, and add to that, our history, pitiful. As noted the PP in the ealier posts. Relying on third party analysis of their science also begs the question as to how much more lethargic can our team get?..,,,what is the technical side of managment doing?,,,,nothing!!,,,its obvious again,,,kicking a can down the road in hope of some foreign entity coming to save them from themselves!!!,,,.I wish I had never heard of this company or of DMcC!!..The team has removed 6 digits of asset value out of my accounts. This is not an investment,,,,it is a roulette table,,,,and a poor one at that,,,one can see the slant in the table to managment's side!!,,Dead $$$ at best out a number of years and a prediction that the C19 trial will end up being a farce with more questions than answers!,,the shorters know this,,,,how they know is a question shareholders should be interested in,,,,,...jmo

 

5
Mar 29, 2022 11:25AM
7
Mar 30, 2022 01:56PM
Share
New Message
Please login to post a reply